Tag Archives: PCFG

OTC Stocks In Focus (TPIV, MWIP, MMTC, PCFG, THRA)

TapImmune Inc. (OTC:TPIV) shares rose 11.06% to $0.261 after the company announced that following FDA IND approval, it will sponsor a Phase I HER-2/neu targeted therapeutic vaccine trial in HER-2/neu positive breast cancer patients at the Mayo Clinic. MediSwipe Inc … Continue reading

Posted in Contributors' Article, Trading Briefs | Tagged , , , , | Leave a comment